{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CK-2017357", "query": { "intervention": "CK-2017357" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 8, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T03:22:55.370Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02496767", "title": "Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Amyotrophic Lateral Sclerosis" ], "interventions": [ { "name": "Tirasemtiv", "type": "DRUG" }, { "name": "Placebo tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 744, "start_date": "2015-09-03", "completion_date": "2017-09-27", "has_results": true, "last_update_posted_date": "2020-09-09", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 49, "location_summary": "Phoenix, Arizona • La Jolla, California • Los Angeles, California + 42 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02496767" }, { "nct_id": "NCT01486849", "title": "Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Amyotrophic Lateral Sclerosis" ], "interventions": [ { "name": "CK-2017357", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Riluzole 50 MG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2011-11", "completion_date": "2012-03", "has_results": false, "last_update_posted_date": "2019-05-03", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 11, "location_summary": "Fresno, California • La Jolla, California • Orange, California + 8 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "New Britain", "state": "Connecticut" }, { "city": "Charlestown", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01486849" }, { "nct_id": "NCT01131013", "title": "A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Intermittent Claudication", "Peripheral Artery Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "375 mg CK-2017357", "type": "DRUG" }, { "name": "500 mg CK-2017357", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 61, "start_date": "2010-05", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2019-05-14", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 14, "location_summary": "Phoenix, Arizona • Santa Ana, California • Stanford, California + 11 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Santa Ana", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01131013" }, { "nct_id": "NCT01089010", "title": "A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Amyotrophic Lateral Sclerosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "250 mg CK-2017357", "type": "DRUG" }, { "name": "500 mg CK-2017357", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2010-03", "completion_date": "2010-11", "has_results": false, "last_update_posted_date": "2019-05-10", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Fresno, California • San Francisco, California + 12 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01089010" }, { "nct_id": "NCT02936635", "title": "A Study for Patients Who Completed VITALITY-ALS (CY 4031)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Amyotrophic Lateral Sclerosis (ALS)" ], "interventions": [ { "name": "tirasemtiv", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2016-10-17", "completion_date": "2018-10-26", "has_results": true, "last_update_posted_date": "2021-06-15", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 41, "location_summary": "Phoenix, Arizona • Los Angeles, California • Orange, California + 36 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02936635" }, { "nct_id": "NCT01709149", "title": "Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Amyotrophic Lateral Sclerosis" ], "interventions": [ { "name": "CK-2017357", "type": "DRUG" }, { "name": "Placebo tablets", "type": "OTHER" }, { "name": "Riluzole", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 711, "start_date": "2012-10", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2020-03-31", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 44, "location_summary": "Phoenix, Arizona • La Jolla, California • Orange, California + 38 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01709149" }, { "nct_id": "NCT01268280", "title": "Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "250 mg CK-2017357", "type": "DRUG" }, { "name": "500 mg CK-2017357", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 32, "start_date": "2010-12", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2019-09-24", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 15, "location_summary": "Fresno, California • Orange, California • San Francisco, California + 12 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "New Britain", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01268280" }, { "nct_id": "NCT01378676", "title": "A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Amyotrophic Lateral Sclerosis" ], "interventions": [ { "name": "Placebo (Part A)", "type": "DRUG" }, { "name": "CK-2017357 (Part A)", "type": "DRUG" }, { "name": "Riluzole 50 MG (Part B)", "type": "DRUG" }, { "name": "Placebo (Part B)", "type": "DRUG" }, { "name": "CK-2017357 (Part B)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2011-06", "completion_date": "2012-03", "has_results": false, "last_update_posted_date": "2019-05-07", "last_synced_at": "2026-09-04T03:22:55.370Z", "location_count": 9, "location_summary": "San Francisco, California • Jacksonville, Florida • Kansas City, Kansas + 6 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01378676" } ] }